KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Co-Diagnostics (CODX) EPS (Basic) (2017 - 2025)

Historic EPS (Basic) for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to -$0.16.

  • Co-Diagnostics' EPS (Basic) rose 5000.0% to -$0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.99, marking a year-over-year increase of 2826.09%. This contributed to the annual value of -$1.24 for FY2024, which is 305.48% down from last year.
  • Latest data reveals that Co-Diagnostics reported EPS (Basic) of -$0.16 as of Q3 2025, which was up 5000.0% from -$0.23 recorded in Q2 2025.
  • Co-Diagnostics' EPS (Basic)'s 5-year high stood at $0.4 during Q3 2021, with a 5-year trough of -$0.7 in Q4 2022.
  • In the last 5 years, Co-Diagnostics' EPS (Basic) had a median value of -$0.2 in 2023 and averaged -$0.12.
  • As far as peak fluctuations go, Co-Diagnostics' EPS (Basic) skyrocketed by 66000.0% in 2021, and later crashed by 40000.0% in 2023.
  • Over the past 5 years, Co-Diagnostics' EPS (Basic) (Quarter) stood at $0.26 in 2021, then tumbled by 367.96% to -$0.7 in 2022, then grew by 28.13% to -$0.5 in 2023, then increased by 27.29% to -$0.36 in 2024, then skyrocketed by 56.0% to -$0.16 in 2025.
  • Its EPS (Basic) was -$0.16 in Q3 2025, compared to -$0.23 in Q2 2025 and -$0.24 in Q1 2025.